CDIO

Cardio Diagnostics Holdings, Inc. NASDAQ Listed Jan 14, 2022

Healthcare ·Biotechnology ·US · cardiodiagnosticsinc.com

$2.04

+1.49% vs $2.01

Mkt Cap $6.0M

52w Low $0.97 15.4% of range 52w High $7.91

50d MA $1.86 200d MA $2.42

P/E (TTM) —

EV/EBITDA —

P/B 0.5x

Debt/Equity 0.1x

ROE -93.2%

P/FCF -0.6x

RSI (14) 67.20

ATR (14) $0.16

Beta 2.66

50d MA $1.86

200d MA $2.42

Avg Volume 80.4K

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

CIK (SEC)

1870144

Phone

855 226 9991

400 N Aberdeen St · Chicago, IL 60642 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Aug 7, 2026	AMC	—	-0.51	—	1.79	+1.1%	-4.5%	+7.0%	+18.0%	-6.9%	—	—
May 15, 2026	AMC	—	-0.63	—	1.55	+0.0%	-10.3%	-1.4%	+3.6%	+6.3%	+6.6%	—
Mar 13, 2026	AMC	-1.80	-0.80	+55.6%	2.80	+0.0%	-13.9%	-6.6%	+3.1%	+6.0%	-6.9%	—
Nov 12, 2025	AMC	-1.80	-0.98	+45.6%	3.74	-1.3%	-9.1%	+0.3%	-12.3%	-8.7%	-6.2%	—
Aug 14, 2025	AMC	-1.80	-0.97	+46.1%	4.02	-0.5%	-9.7%	+2.5%	-1.3%	-4.6%	+4.0%	—
May 15, 2025	AMC	-1.80	-0.97	+46.1%	4.00	-11.0%	-4.0%	+15.1%	+7.7%	-9.0%	-2.1%	—
Mar 20, 2025	AMC	-0.06	-0.01	+83.3%	13.20	+1.8%	+2.3%	-4.0%	+0.2%	-1.2%	-3.4%	—
Nov 13, 2024	AMC	-0.15	-0.06	+60.0%	9.23	-2.5%	-13.8%	-3.9%	+4.4%	-2.4%	-6.0%	—
Aug 12, 2024	AMC	-0.11	-0.06	+45.5%	13.38	+2.1%	-5.8%	+0.0%	+0.7%	+0.0%	+6.4%	—
May 15, 2024	AMC	-0.13	-0.20	-53.8%	25.40	+3.1%	-0.9%	-13.0%	-5.5%	+1.4%	+2.1%	—
Mar 25, 2024	AMC	-0.13	-0.07	+48.0%	39.60	+3.8%	+2.3%	+1.5%	+3.6%	-2.1%	-25.9%	—
Feb 12, 2024	AMC	-0.28	-0.16	+42.9%	57.90	-1.6%	-4.1%	-1.1%	-2.7%	+0.0%	-3.4%	—
Nov 13, 2023	AMC	-0.28	-0.16	+42.9%	33.60	+4.5%	-5.4%	+0.0%	-5.7%	-1.0%	+123.2%	—
Aug 14, 2023	AMC	-0.18	-0.39	-116.7%	27.68	-1.4%	+1.9%	+1.1%	-7.3%	-1.5%	-30.7%	—
May 26, 2023	AMC	-0.18	-0.11	+38.9%	44.10	+1.4%	-1.4%	+2.8%	-4.7%	+0.7%	+1.4%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 27	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$12.30	$12.65	+2.8%	-3.7%	-4.3%	+1.9%	-2.6%	-12.0%
Jun 6	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$20.13	$20.48	+1.7%	+1.5%	-0.5%	-8.5%	-4.4%	+1.1%
Apr 19	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$32.70	$31.20	-4.6%	-20.2%	-13.9%	+0.4%	-0.2%	-3.7%
Jun 15	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$41.10	$42.00	+2.2%	-1.5%	-1.5%	-6.8%	+0.8%	+4.0%

Institutional (13F) — Top 5 All ↗

#	Manager	Shares	Value	Chg	Period
1	Hrt Financial Lp	62,482	$121K	New	Mar 2026
2	Renaissance Technologies Llc	15,348	$30K	New	Mar 2026
3	Ubs Group Ag	9,919	$19K	Added	Mar 2026
4	Morgan Stanley	200	$542	Reduced	Dec 2025
5	Wolverine Asset Management Llc	104	$203	—	Mar 2026

Mutual Funds / ETFs (N-PORT) — Top 4 All ↗

#	Fund	Shares	Value	Period
1	Fidelity Extended Market Index Fund	16,558	$108K	Feb 2026
2	Fidelity Series Total Market Index Fund	2,826	$5K	May 2026
3	Fidelity Total Market Index Fund	2,251	$4K	May 2026
4	Fidelity Nasdaq Composite Index Fund	398	$3K	Feb 2026

Data updated apr 25, 2026 12:29am · Source: financialmodelingprep.com